|
Ustekinumab Clinical Trials
4 actively recruiting trials across 3 locations
Also known as: STELARA, Stelara
Pipeline
Phase 2: 1Phase 3: 1
Top Sponsors
- University of California, San Diego1
- Swiss Dermatology Network for Targeted Therapies1
- M.D. Anderson Cancer Center1
- Janssen Research & Development, LLC1
Indications
- Arthritis3
- Crohn Disease2
- Psoriasis2
- Colitis, Ulcerative1
- Psoriatic Arthritis1
Other1 trial
La Jolla, California1 trial
Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project
University of California, San Diego
Atlanta, Georgia1 trial
A Long-term Extension Study of Ustekinumab in Pediatric Participants
Children's Center For Digestive Healthcare, Llc
Phase 3
Houston, Texas1 trial
Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients
The University of Texas M. D. Anderson Cancer Center
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.